ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 242 filers reported holding ACCELERON PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $485,000 | +21.6% | 2,800 | -12.0% | 0.00% | 0.0% |
| Q2 2021 | $399,000 | -8.3% | 3,181 | -1.6% | 0.00% | 0.0% |
| Q1 2021 | $435,000 | -3.1% | 3,232 | -8.4% | 0.00% | 0.0% |
| Q4 2020 | $449,000 | +28.3% | 3,530 | +13.4% | 0.00% | 0.0% |
| Q3 2020 | $350,000 | +18.6% | 3,114 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $295,000 | +4.6% | 3,114 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $282,000 | +72.0% | 3,114 | 0.0% | 0.00% | – |
| Q4 2019 | $164,000 | -32.2% | 3,114 | -47.1% | 0.00% | -100.0% |
| Q2 2019 | $242,000 | -24.6% | 5,890 | -14.9% | 0.00% | 0.0% |
| Q1 2019 | $321,000 | +50.7% | 6,923 | +36.3% | 0.00% | 0.0% |
| Q4 2018 | $213,000 | -26.8% | 5,080 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $291,000 | +18.3% | 5,080 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $246,000 | +23.6% | 5,080 | 0.0% | 0.00% | – |
| Q1 2018 | $199,000 | -7.4% | 5,080 | 0.0% | 0.00% | -100.0% |
| Q4 2017 | $215,000 | +128.7% | 5,080 | +93.5% | 0.00% | – |
| Q3 2017 | $94,000 | +17.5% | 2,625 | 0.0% | 0.00% | – |
| Q2 2017 | $80,000 | +15.9% | 2,625 | 0.0% | 0.00% | – |
| Q1 2017 | $69,000 | +3.0% | 2,625 | 0.0% | 0.00% | – |
| Q4 2016 | $67,000 | -64.7% | 2,625 | -50.0% | 0.00% | – |
| Q3 2016 | $190,000 | +113.5% | 5,250 | +100.0% | 0.00% | – |
| Q2 2016 | $89,000 | -37.3% | 2,625 | -51.4% | 0.00% | -100.0% |
| Q1 2016 | $142,000 | +79.7% | 5,397 | +231.1% | 0.00% | – |
| Q4 2015 | $79,000 | +92.7% | 1,630 | 0.0% | 0.00% | – |
| Q3 2015 | $41,000 | -19.6% | 1,630 | 0.0% | 0.00% | – |
| Q2 2015 | $51,000 | -17.7% | 1,630 | 0.0% | 0.00% | – |
| Q1 2015 | $62,000 | – | 1,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |